Tune Therapeutics is orchestrating the power of the epigenome to treat complex, pervasive diseases that have long eluded treatment, and to unlock the full potential of regenerative medicine.
Tune Therapeutics
Horizon Quantum Computing
Horizon Quantum Computing is developing a new generation of programming tools to simplify and expedite the process of developing software for quantum computers. By removing the need for prior quantum computing experience to develop applications for quantum hardware, Horizon’s tools will make the power of quantum computing accessible to every software developer.
Boragen
Boragen was formed to develop synthetic fungicides based on a group of boron-containing compounds. In 2022, the company split into three separate companies, 5Metis, Borah and Reactive Biosciences.
EarthOptics
EarthOptics is a soil data measurement and mapping company. Their proprietary sensor technology and data analytics make intelligent soil data accessible on a large scale, for increased agricultural yields and carbon market acceleration, at much lower cost.
5Metis
Founded in 2021, 5Metis is a pure‐play discovery agrichemical company resulting from the union of the former Boragen, Inc. and AgriMetis, LLC agrichemical platforms. The company is focused on the discovery of new molecules with novel modes of action by combining boron‐based small molecule discovery and natural product synthetic biology.
Aktis Oncology
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Designed for high tumor penetration and long residence time, Aktis Oncology's molecules will quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing side effects of treatment. This approach would enable clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes.
NuProbe
NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the sensitivity of sequencing mutations and copy number variations by over 10-fold. NuProbe has sites in Houston, USA, Shanghai, China and Suzhou, China. NuProbe’s vision is to offer affordable, timely, and accurate disease state information to enable precision medicine and improve patient outcomes.
Us2.ai
Us2.ai has developed groundbreaking AI-powered echocardiogram technology that is using machine learning to automate the fight against heart disease, the world’s number one killer. Its FDA-cleared, AI-powered software fully automates a complete echocardiography (heart ultrasound) report, processing full echocardiographic studies of 2D and Doppler images from any vendor, in less than two minutes, and delivering comprehensive cardiac ultrasound measurements that are critical for diagnosis, prediction, and prognosis of heart disease. The complete echo report, with fully explainable measurements, editable annotations, and conclusions for every chamber of the heart, supports improved clinical decision making, increased patient access, and enhanced delivery of care.
Istari Oncology
Istari Oncology is a clinical-stage biotechnology company focused on developing innovative immuno-oncology platforms for the treatment of solid tumors, including glioblastoma and melanoma.
